Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBP vs. PBE: which is better?

Bottom line

BBP vs PBE: the short answer

BBP (Virtus Biotech ETF) and PBE (Invesco Biotechnology & Genome ETF) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.

But BBP is far broader, holding 70 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.

BBP is cheaper at 0.34% vs 0.59% — a difference of $25 a year per $10,000 invested.

Over five years, BBP returned +8.4% a year vs +3.4% for PBE.

Updated Nov 19, 2026

BBP vs PBE side by side

BBPPBE
TypeETFETF
Fund familyVirtusInvesco
CategoryTechnology SectorTechnology Sector
Expense ratio0.34%0.59%
Annual cost per $10k$34$59
10-yr cost on $10k (prospectus)$431$738
Max front loadNoneNone
12b-1 fee——
1-yr return+32.8%+24.7%
5-yr return (annualized)+8.4%+3.4%
10-yr return (annualized)+10.0%+5.2%
Best quarter+28.2%+25.3%
Worst quarter−23.0%−24.3%
Net assets (fund)$98.5M$281.9M
Number of holdings7033
Portfolio turnover29%103%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBPPBEDifference
2025+32.8%+24.7%+8.1%
2024+3.6%+1.1%+2.5%
2023+17.4%+3.7%+13.8%
2022+1.0%−10.8%+11.7%
2021−8.2%+1.6%−9.8%
2020+22.2%+25.5%−3.3%
2019+24.9%+18.3%+6.6%
2018−13.8%+0.2%−14.0%
2017+23.8%+22.4%+1.4%
2016+6.5%−23.0%+29.5%

Source: Fund prospectus bar charts

Holdings overlap

5 of BBP's top 25 holdings also appear in PBE's top 25.

Shared top holdings
HoldingBBPPBE
Regeneron Pharmaceuticals1.72%5.47%
Protagonist Therapeutics Inc1.71%3.40%
Acadia Pharmaceuticals Inc1.69%3.02%
Halozyme Therapeutics Inc1.64%2.98%
Incyte Corp1.52%3.06%

Source: SEC Form N-PORT

BBP top 10

  1. Crinetics Pharmaceuticals Inc — 3.34%
  2. Kiniksa Pharmaceuticals International Plc — 1.97%
  3. Verastem Inc — 1.95%
  4. Precigen Inc — 1.94%
  5. Omeros Corp — 1.87%
  6. Nuvation Bio Inc — 1.77%
  7. Regeneron Pharmaceuticals — 1.72%
  8. Protagonist Therapeutics Inc — 1.71%
  9. Acadia Pharmaceuticals Inc — 1.69%
  10. Bridgebio Pharma Inc — 1.65%

PBE top 10

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Vertex Pharmaceuticals Inc. — 4.99%
  6. Invesco Private Government Fund — 4.97%
  7. Royalty Pharma PLC — 4.94%
  8. Biogen Inc. — 4.79%
  9. Gilead Sciences, Inc. — 4.43%
  10. United Therapeutics Corp. — 4.08%

FAQ

What is the difference between BBP and PBE?
BBP (Virtus Biotech ETF) and PBE (Invesco Biotechnology & Genome ETF) are quite different portfolios: only about 16% of their top holdings (by weight) are shared. But BBP is far broader, holding 70 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.
Which is cheaper, BBP or PBE?
BBP has the lower expense ratio (0.34%).
Should I own both BBP and PBE?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.